Exact Mass: 514.3267372
Exact Mass Matches: 514.3267372
Found 231 metabolites which its exact mass value is equals to given mass value 514.3267372
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N-Docosahexaenoyl Tryptophan
N-docosahexaenoyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Tryptophan is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
1,3,7-Trihydroxy-3,7-dimethyl-2-(3-methylbutanoyl)-6,6-diprenyl-2,3,3a,4,7,7a-hexahydrospiro[1-cyclohexene-4,5(6H)-[1H]indene]-3,5-dione
(22S,24S)-16,24;22,25-dianhydro-16,22,22,24,25-pentahydroxy-2beta-methoxy-3,11-dioxocucurbit-5-ene
3??-Methoxy-16??-hydroxyursa-12,19(29)-dien-27,28-dioic acid
2alpha,3beta-dihydroxy-urs-12,19(29)-dien-28-oic acid|euscaphic acid J
Methyl (24E)-9??,23??-dihydroxy-3,15-dioxo-17,15-friedo-lanostan-8(14),24-dien-26-oate
2,3-seco-22,29-lactone-oleane-12-ene-2,3-dioic acid 3-methyl ester
16-Ac-30(8鈥樏傗垎9)-Abeo-3,11,16-trihydroxyfusida-7,17(20),24-trien-21-oic acid
3,4-secocycloarta-4(28),16,24-(Z)-triene-7beta,15alpha,20beta-trihydroxy-3-oic acid|angustific acid B
(24S)-16,24-anhydro-16,24,25-trihydroxy-2beta-methoxy-3,11,22-trioxocucurbit-5-ene
Ala Ile Arg Arg
Ala Leu Arg Arg
Ala Arg Ile Arg
Ala Arg Leu Arg
Ala Arg Arg Ile
Ala Arg Arg Leu
Ile Ala Arg Arg
Ile Ile Asn Arg
Ile Ile Arg Asn
Ile Leu Asn Arg
Ile Leu Arg Asn
Ile Asn Ile Arg
Ile Asn Leu Arg
Ile Asn Arg Ile
Ile Asn Arg Leu
Ile Gln Arg Val
Ile Gln Val Arg
Ile Arg Ala Arg
Ile Arg Ile Asn
Ile Arg Leu Asn
Ile Arg Asn Ile
Ile Arg Asn Leu
Ile Arg Gln Val
Ile Arg Arg Ala
Ile Arg Val Gln
Ile Val Gln Arg
Ile Val Arg Gln
Leu Ala Arg Arg
Leu Ile Asn Arg
Leu Ile Arg Asn
Leu Leu Asn Arg
Leu Leu Arg Asn
Leu Asn Ile Arg
Leu Asn Leu Arg
Leu Asn Arg Ile
Leu Asn Arg Leu
Leu Gln Arg Val
Leu Gln Val Arg
Leu Arg Ala Arg
Leu Arg Ile Asn
Leu Arg Leu Asn
Leu Arg Asn Ile
Leu Arg Asn Leu
Leu Arg Gln Val
Leu Arg Arg Ala
Leu Arg Val Gln
Leu Val Gln Arg
Leu Val Arg Gln
Asn Ile Ile Arg
Asn Ile Leu Arg
Asn Ile Arg Ile
Asn Ile Arg Leu
Asn Leu Ile Arg
Asn Leu Leu Arg
Asn Leu Arg Ile
Asn Leu Arg Leu
Asn Arg Ile Ile
Asn Arg Ile Leu
Asn Arg Leu Ile
Asn Arg Leu Leu
Gln Ile Arg Val
Gln Ile Val Arg
Gln Leu Arg Val
Gln Leu Val Arg
Gln Arg Ile Val
Gln Arg Leu Val
Gln Arg Val Ile
Gln Arg Val Leu
Gln Val Ile Arg
Gln Val Leu Arg
Gln Val Arg Ile
Gln Val Arg Leu
Arg Ala Ile Arg
Arg Ala Leu Arg
Arg Ala Arg Ile
Arg Ala Arg Leu
Arg Ile Ala Arg
Arg Ile Ile Asn
Arg Ile Leu Asn
Arg Ile Asn Ile
Arg Ile Asn Leu
Arg Ile Gln Val
Arg Ile Arg Ala
Arg Ile Val Gln
Arg Leu Ala Arg
Arg Leu Ile Asn
Arg Leu Leu Asn
Arg Leu Asn Ile
Arg Leu Asn Leu
Arg Leu Gln Val
Arg Leu Arg Ala
Arg Leu Val Gln
Arg Asn Ile Ile
Arg Asn Ile Leu
Arg Asn Leu Ile
Arg Asn Leu Leu
Arg Gln Ile Val
Arg Gln Leu Val
Arg Gln Val Ile
Arg Gln Val Leu
Arg Arg Ala Ile
Arg Arg Ala Leu
Arg Arg Ile Ala
Arg Arg Leu Ala
Arg Val Ile Gln
Arg Val Leu Gln
Arg Val Gln Ile
Arg Val Gln Leu
Val Ile Gln Arg
Val Ile Arg Gln
Val Leu Gln Arg
Val Leu Arg Gln
Val Gln Ile Arg
Val Gln Leu Arg
Val Gln Arg Ile
Val Gln Arg Leu
Val Arg Ile Gln
Val Arg Leu Gln
Val Arg Gln Ile
Val Arg Gln Leu
(2Z)-2-[(3R,4S,8S,9R,10S,13R,14R,16S)-3-hydroxy-4,10,14-trimethyl-11-oxo-16-propanoyloxy-2,3,4,5,6,7,8,9,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid
3-(4-tert-butylphenyl)-1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(4-tert-butylphenyl)-1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(4-tert-butylphenyl)-1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(4-tert-butylphenyl)-1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(4-tert-butylphenyl)-1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
(2r)-2-[(2r,3r,3ar,6s,7s,9br)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-hydroxy-6-methyl-5-methylideneheptanoic acid
(1r,2s,3as,3br,9as,9bs,11r,11as)-11-(acetyloxy)-1-[(2s)-2-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl acetate
ethyl (6r)-6-[(1r,3ar,6s,7r,9as,11r,11ar)-7,11-dihydroxy-6,9a,11a-trimethyl-4,10-dioxo-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoate
2-[6-(2-carboxyethyl)-2-hydroxy-7-(3-hydroxyprop-1-en-2-yl)-3a,6,9b-trimethyl-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid
2-[7-ethenyl-2-hydroxy-6-(3-methoxy-3-oxopropyl)-3a,6,9b-trimethyl-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-hydroxy-6-methyl-5-methylideneheptanoic acid
2-[(1z,2s,3as,3bs,5as,6s,7r,9as,9bs,11ar)-2-(acetyloxy)-7-hydroxy-3a,3b,6,9a-tetramethyl-10-oxo-dodecahydrocyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid
methyl (2r,6r)-6-[(1r,3s,3ar,5ar,9as,11ar)-3-hydroxy-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate
(2r)-2-[(2r,3r,3ar,6s,7r,9br)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-hydroxy-6-methyl-5-methylideneheptanoic acid
(1s,3'r,3'as,7's,7'ar)-3',4,7'-trihydroxy-3',7'-dimethyl-5,5-bis(3-methylbut-2-en-1-yl)-3-[(2r)-2-methylbutanoyl]-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-3-ene-2,6-dione
3β-methoxy-16α-hydroxyursa-12,19(29)-dien-27,28-dioicacid
{"Ingredient_id": "HBIN008274","Ingredient_name": "3\u03b2-methoxy-16\u03b1-hydroxyursa-12,19(29)-dien-27,28-dioicacid","Alias": "NA","Ingredient_formula": "C31H46O6","Ingredient_Smile": "CC1CCC2(C(CC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC)C)C)C2C1=C)C(=O)O)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13964","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5α,8α-Peroxydehydrotumulosic acid
{"Ingredient_id": "HBIN011396","Ingredient_name": "5\u03b1,8\u03b1-Peroxydehydrotumulosic acid","Alias": "NA","Ingredient_formula": "C31H46O6","Ingredient_Smile": "CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C24C=CC5(C3(CCC(C5(C)C)O)C)OO4)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41112","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}